Kalif Eliyahu Sharon 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Kalif Eliyahu Sharon（CIK 1798443）在 1 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-06-16）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-16 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 卖出 | 106,563 | $3.6M |
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 卖出 | 153,251 | $5.5M |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 买入 | 19,916 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 买入 | 33,512 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 买入 | 23,251 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 买入 | 49,800 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 买入 | 141,478 | $0 |
| 2026-03-02 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 卖出 | 345,810 | $11.6M |
| 2025-06-16 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Chief Financial Officer | 卖出 | 55,775 | $952,637 |
来源：SEC Form 4 申报文件 · 截至 2026-06-16